Gerresheimer AG (GXI) Receives €82.16 Average Price Target from Analysts
Gerresheimer AG (ETR:GXI) has received an average recommendation of “Hold” from the nine analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is €79.80 ($93.88).
A number of analysts have weighed in on the company. Commerzbank Ag set a €73.00 ($85.88) price target on Gerresheimer AG and gave the company a “neutral” rating in a research note on Thursday, July 13th. DZ Bank AG restated a “neutral” rating on shares of Gerresheimer AG in a research note on Friday, June 9th. Hauck & Aufhaeuser set a €80.00 ($94.12) price target on Gerresheimer AG and gave the company a “neutral” rating in a research note on Friday, July 14th. Kepler Capital Markets set a €70.00 ($82.35) target price on Gerresheimer AG and gave the stock a “sell” rating in a research report on Thursday, July 13th. Finally, Berenberg Bank set a €83.00 ($97.65) target price on Gerresheimer AG and gave the stock a “buy” rating in a research report on Thursday, June 15th.
Shares of Gerresheimer AG (GXI) traded down 0.162% on Friday, reaching €69.188. The company had a trading volume of 100 shares. Gerresheimer AG has a 52 week low of €64.00 and a 52 week high of €79.47. The company has a market capitalization of €2.17 billion and a P/E ratio of 19.166. The company has a 50 day moving average of €71.04 and a 200-day moving average of €73.13.
Gerresheimer AG Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Receive News & Stock Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related stocks with our FREE daily email newsletter.